Altaseb Beyene Kassaw

Mr. Altaseb Beyene Kassaw

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Contraception and Reproductive Medicine
Verified
Journal Article
Open access
PDF file
GMGosa Mankelkl
Gosa Mankelkl
AKAltaseb Beyene Kassaw
Altaseb Beyene Kassaw
BKBeletu Kinfe
Beletu Kinfe
Background: Globally, sexual and reproductive health is a significant public health issue for women of the reproductive age group. A modern contraceptive method enables individuals and families to manage fertility by reducing unintended pregnancies, abortions, pregnancy-related morbidity, and death. A modern contraceptive method is a drug or medical treatment that prevents sexual activity from leading to pregnancy. However, there is limited reliable and updated data on factors associated with modern contraceptive utilization among reproductive-age women at the national level in Kenya. So, the major goal of this study was to evaluate factors associated with modern contraceptive utilization among women of reproductive age in Kenya at the national level, as evidenced by the 2022 Kenyan demographic and health survey. Methods: The most recent datasets from the Kenyan Demographic and Health Survey were used for secondary data analysis. In all, 14,987 women of reproductive age participated in the investigation. Data for multivariable analysis on the factors influencing modern contraceptive utilization among Kenyan women of reproductive age can be obtained from the Kenyan Demographic and Health Survey. Finally, the odd ratio and percentages were presented along with their 95% confidence intervals. Result: This study includes a total weighted sample of 14,987 reproductive-age women from the Kenyan demographic and health survey. Of the total contraceptive use, 90.1% of the study participants used modern contraceptives. Being married [AOR: 1.593, 95% CI (1.302, 1.948)], living in an urban area [AOR: 1.230, 95% CI (1.060, 1.428)], reading a magazine [1.002, 95% CI (0.921, 1.091)], listening to radio [AOR: 1.265, 95% CI (1.101, 1.454)], not breastfeeding [AOR: 1.296, 95% CI (1.114, 1.507), and having more than two children [AOR: 2.350, 95% CI (1.603, 3.445)] were the factors that promote modern contraceptive utilization. Conversely, having a history of terminated pregnancy [AOR: 0.767, 95% CI (0.657, 0.897), being Muslim [AOR: 0.566, 95% CI (0.418, 0.766)], and being in the 35–39 age range [AOR: 0.766, 95% CI (0.605, 0.971)] were all associated with a lower use of modern contraceptives. Conclusion: Certain factors such as marriage, living in urban areas, having more than two children, having a female-led household, belonging to the middle class, reading magazines, listening to the radio, and not breastfeeding have a positive correlation with the use of modern contraceptives. Conversely, being a Muslim, aged between 35 and 39, and having a history of miscarriages are negatively correlated with the use of modern contraceptives. This indicates that addressing socioeconomic, geographic, and cultural barriers could improve the effectiveness of modern contraceptive.

8 October 2024 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
AKAltaseb Beyene Kassaw
Altaseb Beyene Kassaw
MBMekonnen Belete
Mekonnen Belete
EAEbrahim Msaye Assefa
Ebrahim Msaye Assefa
ATAmare Abera Tareke
Amare Abera Tareke
Urolithiasis, the presence of stones in the urinary tract, has been linked to various clinical features and reported as a worldwide health concern. Its prevalence varies across different regions as well as populations. Several primary studies have been conducted in Sub-Saharan Africa on the situation. However, their reports are inconsistent. Hence, this review aimed to assess the pooled magnitude of urolithiasis and its clinical patterns among hospital-visiting patients in sub-Saharan Africa. Online databases such as PubMed, Hinari, the African Journals online database, and Google Scholar were used to comprehensively search articles published until June 28, 2023, about the prevalence and clinical patterns of urolithiasis in Sub-Saharan Africa. All the included studies were conducted at hospital setting. The retrieved data was exported to STATA version 16 for final analysis. A random-effect meta-analysis model was computed to estimate the pooled results. The heterogeneity of the studies was assessed using I2 and Cochran’s Q. Publication bias was examined by observation using funnel plots and statistically by Egger’s tests. Subgroup analysis was performed based on the country where the studies have been conducted. A total of 26 articles (11 reported both prevalence and clinical pattern, 5 reported only prevalence, and 10 reported only clinical patterns of urolithiasis) were included in the final systematic review and meta-analysis. The pooled prevalence of urolithiasis among hospital-visiting patients was 9.4% (95% CL = 4.9–14%), with significant heterogeneity. Most of the urolithiasis was located in the kidney, with an estimated pooled proportion of 4.6% (95% CI = 2.7, 6.5), followed by bladder stone-2.0% (95% CI = 0.7, 3.4), ureteral stone-1.8% (95% CI = 0.7, 2.9), and urethral stone-0.2% (95% CI = 0.00, 0.05). The subgroup analysis showed the highest prevalence of urolithiasis was found in Mauritian, 28.1% (95%CI 24.5, 31.7), followed by Ethiopia 18.1%, and the lowest was in Eritrea, 1.0%. A sensitivity analysis using the random-effects model found no influential study on the pooled prevalence of urolithiasis. Evidence of significant publication bias was observed and trim-fill analysis was conducted for adjustment. Accordingly, two missing studies were identified, and after adjustment, the combined prevalence of urolithiasis was estimated to be 10.7%. The study also found that urolithiasis prevalence per gender was 6.3% in males and 2.9% in females. The most common clinical presentation of urolithiasis was flank pain at 58.4% (95% CL=, 45.9, 70.8), followed by low back pain at 45.9% (95% CL=, 23.1, 68.8), and nausea/vomiting at 29.9% (95% CI: 1 1.1, 48.8). The prevalence of urolithiasis in Sub-Sahara African Countries is increasing even though a remarkable regional variation was observed, with higher predominance in males than females. Common clinical presentations of urolithiasis were flank pain, low back pain, and nausea/vomiting.

29 December 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAltaseb Beyene Kassaw
Altaseb Beyene Kassaw
HEHiwot Tezera Endale
Hiwot Tezera Endale
KTKibur Hunie Tesfa
Kibur Hunie Tesfa
MMMeseret Derbew Molla
Meseret Derbew Molla
Introduction: Metabolic syndrome is a group of metabolic risk factors which are associated with an increased risk of cardiovascular disease and type2 diabetes. Nowadays, several studies have shown that the burden of metabolic syndrome is increasing among epileptic patients, and leads to MS-associated complications, including cardiovascular disease. However, getting published documents has been limited in Ethiopia and the study area. Therefore, we aimed to analyze the magnitude and associated factors of metabolic syndrome among epileptic patients in Dessie Comprehensive Specialized Hospital in compression with respective controls.Methods: Hospital-based comparative cross-sectional study design was implemented from June 25 to August 20, 2021. A total of 204 participants with an equal number of cases and controls (n = 102 each) were included. The data was collected through face-to-face interviews and biochemical analyses such as fasting blood glucose and lipid profiles were done through the enzymatic technique. The magnitude of metabolic syndrome was determined using both National Cholesterol Education Program Adult Treatment Panel III and International Diabetes Federation definition criteria. The STATA version 14 was used for statistical data analysis, and a comparison of categorical and continuous variables was done with χ2and an independent t-test, respectively. The multivariable binary logistic regression analysis was used to identify factors associated with metabolic syndrome, and variables having aP-value of <0.05 were considered statistically significant.Result: The prevalence of metabolic syndrome among the epileptic group was (25.5% in National Cholesterol Education Program Adult Treatment Panel III and 23.5% in International Diabetes Federation criteria), whereas it was 13.7% in National Cholesterol Education Program Adult Treatment Panel III and 14.7% in International Diabetes Federation criteria among control groups. According to the International Diabetes Federation criteria, low physical activity (adjusted odds ratio = 4.73, 95% CI: 1.08–20.68), taking multiple antiepileptic drugs (adjusted odds ratio = 8.08, 95% CI: 1.52–42.74), having a total cholesterol level of ≥ 200 mg/dl (adjusted odds ratio = 5.81, 95%: 1.32–41.13) and body mass index (adjusted odds ratio = 1.57, 95% CI = 1.16–2.11) were significantly associated with metabolic syndrome among epileptic participants. Applying National Cholesterol Education Program Adult Treatment Panel III criteria, taking multiple antiepileptic drugs (adjusted odds ratio = 6.81, 95% CI: 1.29–35.92), having a total cholesterol level > 200 mg/dl (adjusted odds ratio = 7.37, 95% CI: 1.32–41.13) and body mass index (adjusted odds ratio = 1.53, 96% CI: 1.16–2.01) were also significantly associated.Conclusion: The prevalence of metabolic syndrome among epileptic patients was higher than that of control groups and reaches statistically significant by National Cholesterol Education Program Adult Treatment Panel III. Being on multiple antiepileptic drugs, body mass index, having low physical activity and raised total cholesterol were significantly associated with metabolic syndrome among the epileptic group. Therefore, it is better to focus on controlling weight, having sufficient physical exercise, and regular monitoring of total cholesterol levels in epileptic patients.

24 February 2025 in Malaria Journal
Verified
Journal Article
Open access
PDF file
MAMikiyas Shemelis Achame
Mikiyas Shemelis Achame
AGAlemu Gedefie
Alemu Gedefie
HDHabtu Debash
Habtu Debash
ATAndualem Tesfaye
Andualem Tesfaye
KTKeleb Takele Tiruneh
Keleb Takele Tiruneh
AKAltaseb Beyene Kassaw
Altaseb Beyene Kassaw
Thrombocytopenia is a common haematological abnormality in malaria patients that is associated with an increased risk of mortality. Given the endemic nature of malaria in Ethiopia, it is crucial to comprehend the prevalence of thrombocytopenia in this setting to enhance clinical care. Therefore, this study aimed to systematically review and synthesize the available evidence on the prevalence of thrombocytopenia among malaria patients in Ethiopia. This systematic review and meta-analysis reviewed studies on thrombocytopenia prevalence in malaria patients, using databases including PubMed, Google Scholar, EMBASE, African Journals online database, and Hinary. STATA version 17 software was used for statistical analysis. A random-effects model was used to estimate pooled effect sizes. Heterogeneity among the included studies was assessed using Galbraith, Cochran’s Q test, and I2 statistics. Subgroup analysis, sensitivity analysis, and meta-regression were conducted to identify the source of heterogeneity. Publication bias was evaluated using a funnel plot and Egger's test. Of the 154 studies identified, 31 that fulfilled the eligibility criteria were included in the meta-analysis consisting of 1173 study participants and 823 thrombocytopenic cases. The pooled prevalence of thrombocytopenia was 70% (95% CI: 63, 77) with significant heterogeneity. Subgroup analysis showed the highest pooled prevalence of thrombocytopenia in the Southern Nations Nationalities and Peoples’ region (78.34%) followed by the Amhara region (69.7%), whereas the lowest prevalence was observed in the Gambella Region (63.4%). The sample size was responsible for the observed heterogeneity among the studies, as indicated by the statistically significant result in the meta-regression analysis (p = 0.001). Thrombocytopenia is a frequent abnormality finding among malaria patients in Ethiopia, affecting a substantial percentage of individuals. The high frequency found in this research emphasizes the significance of regular platelet monitoring in the treatment of malaria patients. Further studies are needed to investigate the clinical implications of thrombocytopenia in malaria patients.

24 June 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAltaseb Beyene Kassaw
Altaseb Beyene Kassaw
AHAddis Alem Hadigu
Addis Alem Hadigu
MAMelese Shenkut Abebe
Melese Shenkut Abebe
ATAmare Abera Tareke
Amare Abera Tareke
WDWondwossen Debebe
Wondwossen Debebe
AGAlemu Gedefie
Alemu Gedefie
Background: Diabetes mellitus is a growing global public health challenge, especially in low- and middle-income regions like sub-Saharan Africa, where healthcare resources are often limited. One of its most debilitating complications is vision impairment, which significantly impacts the quality of life, productivity, and independence of individuals. Although several studies have assessed the prevalence of vision impairment among individuals with diabetes in sub-Saharan Africa, their findings have been inconsistent and fragmented across different areas. A comprehensive synthesis of this evidence is crucial for informing healthcare planning, early screening, and management strategies. This study aimed to systematically review and synthesize the existing evidence on the prevalence of vision impairment among patients with diabetes mellitus in the region. Methods: A literature exploration was done in an electronic database such as PubMed, Google Scholar, Web of Science, Hinary, and African Journals Online. We included all observational studies reporting the prevalence of vision loss among diabetes mellitus patients in Sub-Saharan Africa. A random-effect meta-analysis model was computed to estimate the pooled prevalence of vision impairment. I2 test and Cochrane Q test statistics were used to assess the heterogeneity of the studies. Subgroup analysis was done based on the countries where the research was conducted. STATA Version 16 statistical software was used for data analysis. Publication bias was examined by funnel plots and Egger’s tests. Results: Only 26 studies with 12508 participants, contributing data from 14 countries within Sub-Saharan Africa, met the inclusion criteria for the final analysis. The overall pooled prevalence of visual impairment was found to be 29% (95% CI: 22%−35%). Heterogeneity was observed among included studies (p < 0.001 for high I2 values). Subgroup analysis revealed the source of heterogeneity in the studies carried out in Ethiopia (I2 = 99.2%, p = < 0.001), Nigeria (I2 = 94.59%, p = < 0.001), and Zambia (I2 = 77.34%, p = 0.036). Conclusion: The findings of this study indicated that the pooled prevalence of vision impairment among diabetes mellitus patients is relatively higher. It can be concluded that diabetes mellitus patients should be managed properly to prevent visual impairment. Early detection of visual impairment through screening and regular follow-up is recommended to reduce as well as control the burden of visual impairment and its impact on the diabetic population.

7 January 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
AKAltaseb Beyene Kassaw
Altaseb Beyene Kassaw
MAMihiret Bogale Abera
Mihiret Bogale Abera
MSMohammed Abdu Seid
Mohammed Abdu Seid
MJMohammed Jemal
Mohammed Jemal
HAHassen Ahmed
Hassen Ahmed
ZGZeleke Geto
Zeleke Geto
Mutations in the KRAS gene serve as significant oncogenic drivers in colorectal cancer (CRC), greatly affecting therapy response and prognosis. While the p